Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Collegium Pharmaceutical (COLL) EBT Margin (2016 - 2025)

Historic EBT Margin for Collegium Pharmaceutical (COLL) over the last 10 years, with Q3 2025 value amounting to 20.75%.

  • Collegium Pharmaceutical's EBT Margin rose 109700.0% to 20.75% in Q3 2025 from the same period last year, while for Sep 2025 it was 10.68%, marking a year-over-year decrease of 106800.0%. This contributed to the annual value of 15.61% for FY2024, which is 22500.0% up from last year.
  • Collegium Pharmaceutical's EBT Margin amounted to 20.75% in Q3 2025, which was up 109700.0% from 9.06% recorded in Q2 2025.
  • Collegium Pharmaceutical's 5-year EBT Margin high stood at 31.19% for Q4 2023, and its period low was 142.08% during Q4 2021.
  • Moreover, its 5-year median value for EBT Margin was 9.78% (2024), whereas its average is 1.08%.
  • Per our database at Business Quant, Collegium Pharmaceutical's EBT Margin plummeted by -1516000bps in 2021 and then surged by 1360700bps in 2022.
  • Over the past 5 years, Collegium Pharmaceutical's EBT Margin (Quarter) stood at 142.08% in 2021, then soared by 96bps to 6.01% in 2022, then skyrocketed by 619bps to 31.19% in 2023, then tumbled by -70bps to 9.49% in 2024, then skyrocketed by 119bps to 20.75% in 2025.
  • Its EBT Margin stands at 20.75% for Q3 2025, versus 9.06% for Q2 2025 and 1.76% for Q1 2025.